Ivermectin Dosing for Parasitic Infections
The standard dose of ivermectin for most parasitic infections is 200 mcg/kg (0.2 mg/kg) as a single oral dose taken on an empty stomach with water. 1, 2
Standard Dosing by Indication
Intestinal Nematodes
Cutaneous larva migrans: 200 mcg/kg as a single dose 3
- Alternative regimen: 200 mcg/kg once daily for 2 days 3
Hookworm, Ascariasis, Enterobiasis: 200 mcg/kg single dose 5
- Note: Albendazole is superior for hookworm (98% cure rate vs ivermectin) and should be preferred 4
Filarial Infections
Onchocerciasis: 150-200 mcg/kg as a single oral dose 3, 2, 6
- Initial treatment: 200 mcg/kg monthly for 3 months starting on day one of doxycycline 200 mg daily for 6 weeks 3
- Maintenance: Repeat every 3-6 months until asymptomatic, then annually for several years 3
- FDA-approved dosing is 150 mcg/kg, with retreatment intervals as short as 3 months or up to 12 months in mass campaigns 2
Lymphatic filariasis: 200 mcg/kg single dose 7
Loiasis: 150-200 mcg/kg, with dosing frequency (single, monthly, quarterly, or biannual) dependent on microfilarial load 1
Ectoparasites
Pediculosis: 200 mcg/kg with two doses 10 days apart achieves 99% cure rate 5
Critical Administration Requirements
Timing and Food Interactions
- Must be taken on an empty stomach with water to optimize bioavailability 1, 2
- This is a non-negotiable requirement for proper absorption 1
Weight-Based Tablet Dosing
For strongyloidiasis (200 mcg/kg) using 3-mg tablets 2:
- 15-24 kg: 1 tablet
- 25-35 kg: 2 tablets
- 36-50 kg: 3 tablets
- 51-65 kg: 4 tablets
- 66-79 kg: 5 tablets
- ≥80 kg: Calculate 200 mcg/kg
Essential Safety Precautions
Pre-Treatment Screening
Always exclude Loa loa infection before treating with ivermectin in anyone who has traveled to endemic regions (Central/West Africa) 3, 1
- Ivermectin can cause severe adverse events including encephalitis in hypermicrofilaremic patients (>8,000 mf/mL) with loiasis 4, 1
- Similarly, exclude onchocerciasis before treating loiasis, and exclude loiasis before treating lymphatic filariasis or onchocerciasis 1
Special Populations
- Pregnancy: Classified as "human data suggest low risk" 1
- Breastfeeding: Probably compatible 1
- Renal impairment: No dose adjustment required 1
- Severe liver disease: Safety of multiple doses not established 1
- Elderly/debilitated patients: One study showed increased mortality, though not confirmed in subsequent reports; use with caution 1
Monitoring
- Albendazole (often used in combination) can cause hepatotoxicity and leukopenia with prolonged use, requiring liver enzyme and blood count monitoring 4
- Ivermectin itself is generally well-tolerated with side effects confined to the first 5 days 7
Empirical Treatment Strategy
For travelers with eosinophilia and negative stool studies, consider empirical treatment with albendazole 400 mg plus ivermectin 200 mcg/kg as a single dose to cover prepatent or undetected geohelminth infections 3, 4